Key facts
- This page summarizes Kevin Berg's Form 4 filing for CareMax, Inc..
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 21 Nov 2023, 18:07.
Kevin Berg - 17 Nov 2023 Form 4 Insider Report for CareMax, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 17 Nov 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 Nov 2023, 18:07:48 UTC
- Prior SEC filing
- 12 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kevin Berg
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Kevin Berg filed Form 4 for CareMax, Inc. on 21 Nov 2023.
Change
- Previous filing in this sequence was filed on 12 Jun 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CMAX
transaction
Class A Common Stock
Options Exercise
- Transaction value
- Shares
- +12,123
- Change %
- Price
- Shares after
- 12,123
- Date
- 17 Nov 2023
- Ownership
- Direct
- Footnotes
- F1, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CMAX
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -12,123
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 17 Nov 2023
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 12,123
- Exercise price
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The reported transaction involved the vesting and settlement of 12,123 restricted stock units ("RSUs") on November 17, 2023. On such date, each such RSU vested in full and converted into Class A common stock of the Issuer on a one-for-one basis.
Footnote F2
Each RSU was awarded on November 17, 2022, vested on November 17, 2023 and represented a contingent right to receive one share of the Issuer's Class A common stock in accordance with the Issuer's 2021 Long-Term Incentive Plan.
Footnote F3
The Reporting Person, an employee of Deerfield Management Company, L.P. ("Deerfield Management"), holds the securities reported herein for the benefit, and at the direction, of Deerfield Management. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the Reporting Person disclaims beneficial ownership of such securities, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.